Thursday, May 21, 2026

NOAA Predicts Below-Normal 2026 Atlantic Hurricane Season

 

CLIMATE PREDICTION CENTER/NCEP/NWS: El Niño is likely to emerge soon (82% chance in May-July 2026) and continue through Northern Hemisphere winter 2026-27 (96% chance in December 2026-February 2027).

#19,170

While there are a great many potentially negative impacts to global weather from the forecasted (moderate-to-strong) El Niño, the one bright spot for those of us who live along the Atlantic and Gulf coasts is its tendency to dampen the intensity of the Atlantic Basin Hurricane season. 

Hurricanes will undoubtedly still appear, but during El Niño conditions, they tend to be less frequent.  And after the battering the Gulf States have taken over the past decade, any respite is a welcome one. 

Today, NOAA released their 2026 Atlantic Hurricane outlook which predicts a below-normal season ahead.  The caveat being, that one of the worst storms in decades - 1992's Cat 5 Hurricane Andrew - struck during a relatively quiet  El Niño year. 


As they say, it only takes one. Which is why I'll prep this year with the same intensity as I do every year (see past blogs here, here, here, and here).  

Some excerpts from today's announcement from NOAA:

NOAA predicts below-normal 2026 Atlantic hurricane season

Early preparation essential to staying safe all season

May 21, 2026


A NOAA satellite view of a massive Hurricane Erin churning off the U.S. East Coast taken August 20, 2025. (Image credit: NOAA Satellites)
Download Image

RESOURCES

NOAA Research: New technology, advanced models and AI deployed to improve hurricane forecasting

2026 Atlantic Hurricane Season Outlook - Spanish

2026 Atlantic hurricane names graphic - Spanish


Forecasters with NOAA’s National Weather Service are predicting a below-normal hurricane season for the Atlantic basin this year. NOAA’s outlook for the 2026 Atlantic hurricane season, which runs June 1 to November 30, predicts a 35% chance of a near-normal season, a 10% chance of an above-normal season, and a 55% chance of a below-normal season.

The agency is forecasting a total of 8-14 named storms (winds of 39 mph or higher). Of those, 3-6 are forecast to become hurricanes (winds of 74 mph or higher), including 1-3 major hurricanes (category 3, 4 or 5 with winds of 111 mph or higher). NOAA has a 70% confidence in these ranges. An average season has 14 named storms with seven hurricanes, including three major hurricanes.

“With the most advanced forecast modeling and hurricane tracking technologies, NOAA and the National Weather Service are prepared to deliver real-time storm forecasts and warnings,” said Commerce Secretary Howard Lutnick. “Our experts are integrating cutting-edge tools to ensure communities in the path of storms receive the earliest, most accurate information possible.”

“NOAA’s rapid integration of advanced technology, including AI-based weather models, drones, and next-generation satellite data will deliver actionable science to safeguard the lives and livelihoods of the American people,” said NOAA Administrator Neil Jacobs, Ph.D. “These new capabilities, combined with the unmatched expertise of our National Weather Service forecasters, will produce the most accurate forecasts possible to protect communities in harm’s way.”

(Continue . . . )

If this is your first hurricane season - or you would just like a refresher - you'll find a number of short videos on hurricane prepareded at this NOAA website:

Hurricane Prep: social media (English)

The Hurricane Preparedness Week Social Media Plan

2026 SOCIAL MEDIA PLANS AND VIDEOS English: May 3 - May 9, 2026

En español: 3 de mayo - 9 de mayo de 2026

Chinese: 年5月3日 - 2025年5月9日

Vietnamese: Ngày 3 Tháng 5, Năm - Ngày 9 Tháng 5, Năm 2026

English: Videos

En español: Videos

#HurricaneStrong #HurricanePrep

Please help the NWS spread the word about Hurricane Preparedness Week (May 3-May 9, 2026) on social media! Everyone is welcome to use the text and images provided below to help the NWS build a Weather-Ready Nation.

May 3, 2026 Know Your Risk: Wind & Water

May 4, 2026 Prepare Before Hurricane Season

May 5, 2026Understand Forecast Information

May 6, 2026Get Moving When a Storm Threatens

May 7, 2026 Stay Protected During Storms

May 8, 2026 Use Caution After Storms

May 9, 2026Take Action Today

And a reminder, you don't have to live on the coast to be impacted by a hurricane or tropical storm.  Often flooding, high winds, and even tornadoes are reported hundreds of miles inland, and days after landfall.  

While this blog, and many other internet sources (I follow Mark Sudduth's Hurricane Track, and Mike's Weather page), will cover this year's hurricane season. your primary source of forecast information should always be the National Hurricane Center in Miami, Florida.

These are the real experts, and the only ones you should rely on to track and forecast the storm.

If you are on Twitter, you should also follow @FEMA, @NHC_Atlantic, @NHC_Pacific and @ReadyGov and of course take direction from your local Emergency Management Office


MMWR: Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks

 

#19,169

Although numbers vary between published sources, since 2020 there has been a significant increase in the number of people who have decided to raise backyard poultry - especially hens for eggs - across the United States (see Chicken Coops Market Outlook 2025 to 2035).

The APPA estimates `Eleven (11) million U.S. households own backyard chickens (a 28% increase from 2023)'
 
Since late 2021, HPAI H5 avian influenza has become endemic in wild North American birds, and has affected both commercial and backyard poultry flocks in all 50 states (see graphic below).


 While the CDC has released biosafety guidelines (see Backyard Flock Owners: Protect Yourself from Bird Flu) - it is unknown how many backyard poultry owners have actually read it, or would be willing to follow their recommendations. 


And while H5Nx is our biggest concern, there are other avian subtypes which have been reported in North America with zoonotic potential, including several subtypes of H7. 

Over the past 18 months we've seen at least 3 U.S. backyard flock owners infected with HPAI H5, resulting in 2 deaths. This is an all-too familiar pattern, which we've seen repeated dozens of times in many other countries. 

Last year, after Hawaii's first detection of H5N1, their DOH conducted a survey of local residents aged 18 years or older who either kept birds at home, performed animal rescue, or engaged in other bird-related activities.  The results indicated more education was needed:

All of which brings us to a new survey, published last week in the CDC's MMWR, which looks at similar knowledge and practices among backyard poultry owners in the United States.  It is subject to some significant limitations, including:

  • This survey used an online convenience sample of highly educated (47% held held graduate or professional degrees) respondents, which is far higher than the general population (and likely target group of backyard poultry owners). 

But, it's a starting point.  And even with these advantages, the survey turned up some important gaps in knowledge about avian flu. I've posted the summary, abstract, and some excerpts from the MMWR report below. 

Follow the link to read it in its entirety. I'll have a bit more after the break.

Knowledge, Attitudes, and Practices Regarding Avian Influenza Among Owners of Backyard Flocks — United States, July–December 2025

Weekly / May 14, 2026 / 75(18);234–239
Print

Melissa A. Rolfes, PhD1; Leah Bauck, MPH2; Beth A. Lipton, DVM3; Sara F. Margrey, DVM4; Rebecca A. Campagna, DVM5; Elizabeth Harker, MPH1; Colin A. Basler, DVM6; Courtney M. Dewart, PhD4,7; Sascha R. Ellington, PhD1; Stacy M. Holzbauer, DVM2,7; Malia J. Ireland, DVM2; Jeremy W. Kuo, MPH8; Christine M. Szablewski, DVM1; Lizette O. Durand, PhD, VMD1; Carrie Reed, DSc1 (VIEW AUTHOR AFFILIATIONS)View suggested citation


Summary

What is already known about this topic?

Since 2024, three human influenza A(H5) cases have been reported among people in the U.S. who own backyard birds. Although previous surveys suggest that backyard flock owners are aware of avian influenza, information on knowledge, attitudes, and practices is needed to guide development of education and prevention materials.

What is added by this report?

A survey of 638 U.S. backyard flock owners revealed incomplete knowledge about signs and symptoms of avian influenza in humans and birds. Respondents who knew more about avian influenza were more likely to report an intention to use personal protective equipment if they were to interact with potentially infected birds.

What are the implications for public health practice?

Education of backyard flock owners by health partners regarding signs and symptoms of avian influenza can help flock owners keep their flocks, themselves, and their families healthy.
Article PDF
Full Issue PDF

Abstract

Many U.S. households keep backyard bird flocks for their personal food supply or as garden partners. Backyard flocks in the United States have occasionally been infected with avian influenza A viruses, putting flock owners at risk for exposure. During July–December 2025, CDC, in collaboration with state health and agricultural partners, conducted an online survey to learn more about backyard flock owners and their knowledge, attitudes, and practices related to avian influenza.
Among 638 respondents who completed the survey, 92% were White (and not Hispanic or Latino), and approximately one half had a graduate or professional degree; a majority kept small, predominantly chicken flocks; and many reported that wild birds could access their flock or the flock’s food or water, which increases the flock’s risk for avian influenza exposure.
Although a majority of respondents had heard of avian influenza, approximately one third were unaware of the signs and symptoms of infection in their birds or humans. If they needed to interact with ill or dead birds, a majority of owners knew the recommended precautions to take and indicated willingness to use most, though not all, recommended personal protective equipment. These findings highlight important topics for risk messaging and educational resources so that backyard flock owners are better informed and better able to protect their flocks, themselves, and their families from avian influenza.
Introduction

Avian influenza A(H5) viruses, commonly referred to as bird flu, circulate among wild waterfowl and seabirds and are causing outbreaks in domestic poultry, dairy cows, and other mammals in the United States; 71 human cases of influenza A(H5) have been reported in the United States since March 2024. Three of these cases, including two deaths (1–4), occurred among persons who were owners of backyard flocks.

Surveys of U.S. backyard flock owners conducted in 2013 (5) and 2018 (6), found that a majority of respondents kept small flocks (fewer than 10 birds, primarily chickens) for <5 years. Most respondents were aware of avian influenza, and few reported using personal protective equipment (PPE) during regular interactions with their birds (6). To update and build on previous surveys, CDC and state partners conducted a survey among backyard flock owners aimed to assess knowledge of specific signs and symptoms of avian influenza and planned practices if their flock were to become infected with avian influenza viruses. These data might help guide and refine public health messaging to U.S. backyard flock owners.

 (SNIP)

Discussion

A majority of surveyed U.S. backyard flock owners had heard about avian influenza, were aware that U.S. backyard flocks have been infected, and knew that human cases of avian influenza have occurred in the United States. However, important gaps in knowledge and prevention practices remain among flock owners, suggesting opportunities for focused public health, animal health, and agricultural outreach.

(SNIP)

Backyard flock owners should know how to protect themselves from avian influenza. Although most survey respondents reported willingness to use some types of PPE, fewer indicated they would use eye protection or coveralls. Messages to flock owners could highlight reasons to use each piece of recommended PPE, when to use it, and how to use it correctly.

Recent incidences of influenza A(H5) human cases among backyard flock owners in the United States underscore the importance of flock owners knowing the signs and symptoms of possible human A(H5) virus infection. The survey identified limited awareness of nonrespiratory symptoms of avian influenza in humans (such as conjunctivitis, diarrhea, and vomiting) and low perceived personal risk, which could result in delays in seeking health care. Flock owners should be encouraged to seek prompt medical evaluation for any potential symptoms of avian influenza virus infection and report recent bird exposure to health care providers to support timely diagnosis and further infection prevention and control measures

(Continue . . . )


The need to improve both knowledge and biosecurity practices among backyard flock owners isn't just an American problem.  

Last March, in EFSA: Risk communication on Avian Flu Biosecurity, we looked at a proposed, phased 3-year program to increase biosecurity awareness in small holdings across the EU. 

As we discussed in 2024's Mixed Messaging On HPAI Food Safety, there is some degree of risk in the slaughtering of live birds and preparation of raw poultry; especially from birds raised at home or purchased from live markets.

PAHO (the Pan-American Health Organization) mentions this on their Avian Influenza landing page Plucking, handling infected poultry carcasses, and preparing poultry for consumption, especially in domestic settings, may also be risk factors.

Also in 2024 the WHO published  Interim Guidance to Reduce the Risk of Infection in People Exposed to Avian Influenza Viruses, which lists a number of `risk factors', including:

  • keep live poultry in their backyards or homes, or who purchase live birds at markets;
  • slaughter, de-feather and/or butcher poultry or other animals at home;
  • handle and prepare raw poultry for further cooking and consumption;
Over the past few years the threat from H5N1 has grown markedly in the Western Hemisphere. Things we used to do without much thought - like raising a few chickens the backyard - carry more risks today. 

The $64 question is whether we can adjust to those changing risks fast enough to prevent even bigger bio-shocks in the future. 

Wednesday, May 20, 2026

CDC HAN #00530: Ebola Disease Outbreak in the Democratic Republic of the Congo and Uganda

 
Credit CDC

#19,168

While the full extent of the Ebola outbreak in the DRC and neighboring countries remains unclear, we are already seeing numbers that suggest this virus is spreading rapidly in the community.   

The latest CDC update reads:

New developments
  • On May 17, an American who was exposed as part of their work caring for patients in DRC tested positive for Ebola Bundibugyo disease.
    • The person developed symptoms over the weekend and tested positive late on Sunday.
    • CDC is working hand-in-hand with the U.S. Department of State to move the patient to Germany for treatment and care. In addition to being a shorter flight time, Germany has previous experience caring for Ebola patients.
    • High-risk contacts associated with this exposure are also being moved to Germany. 
  • As of May 19, the DRC and Uganda Ministries of Health report the following:
    • A total of 536 suspected cases, 105 probable cases, 34 confirmed cases, and 134 deaths
    • In the last 24 to 48 hours, 26 new confirmed cases and 143 new suspected cases were identified,
    • These numbers include 2 confirmed cases including 1 death in Uganda in people who traveled from DRC. No further spread has been reported.
  • This is a rapidly evolving situation, and case counts are subject to change.
  • More information about enhanced travel security measures is forthcoming.

Late yesterday afternoon the CDC issued the following lengthy HAN Advisory.  I've only posted some excerpts.  Those with specific interests (clinicians, public health workers, lab techs, etc.) will want to read the advisory in its entirety. 

I'll have a brief postscript after the break. 

Ebola Disease Outbreak in the Democratic Republic of the Congo and Uganda
May 19, 2026


 Distributed via the CDC Health Alert Network
May 19, 2026
CDCHAN-00530

Summary

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert clinicians, public health practitioners, and travelers about a new outbreak of Ebola disease in the Democratic Republic of the Congo (DRC) and Uganda caused by the Bundibugyo virus (species Orthoebolavirus bundibugyoense).
The risk of spread to the United States is considered low at this time. As a precaution, this Health Advisory summarizes CDC recommendations for U.S. health departments, clinical laboratories, and healthcare workers about potential Ebola disease case identification, testing, and biosafety considerations in clinical laboratories.

Background

On May 15, 2026, the Ministry of Health of the Democratic Republic of the Congo (DRC) confirmed an outbreak of Ebola disease in Ituri Province in northeastern DRC. As of May 16, 2026, a total of 246 suspected cases and 80 deaths have been reported. Laboratory analysis conducted by the National Institute of Biomedical Research (INRB) confirmed the cause as Bundibugyo virus infection in 8 of 13 samples collected from suspected cases associated with clusters of severe illness and deaths in the Mongbwalu and Rwampara health zones in Ituri Province. Patients presented with symptoms including fever, generalized body pain, weakness, vomiting, and in some cases bleeding. Several patients reportedly deteriorated rapidly and died. The outbreak is occurring in areas affected by insecurity, population displacement, mining-related population movement, and frequent cross-border travel, all of which may increase the risk of further transmission. In neighboring Uganda, health authorities confirmed Bundibugyo virus disease (BVD) in a patient who had traveled from DRC and later died while receiving care. Ugandan authorities have activated surveillance, screening, and response measures.

On May 15, 2026, CDC issued a Level 1 Travel Health Notice for people traveling to Uganda and a Level 3 Travel Health Notice for people traveling to DRC. On May 17, the World Health Organization determined this outbreak to be a public health emergency of international concern. As of May 18, no suspected, probable, or confirmed Ebola cases related to this outbreak have been reported in the United States.

This is the 17th recorded Ebola outbreak in DRC since the virus was first identified in 1976. The previous Ebola outbreak in DRC ended in December 2025. The Bundibugyo species of Ebola virus was first identified in Uganda in 2007 and has historically been associated with somewhat lower case fatality rates than other species of Ebola virus disease, though severe disease and death can still occur. Previous outbreaks of BVD have had mortality rates of approximately 25%-50%.

CDC is working through its country offices and partners in DRC and Uganda to provide technical assistance with disease tracking and contact tracing, laboratory sample collection and testing, virus sequencing, infection prevention and control (IPC) efforts, border health screening, and coordination with affected countries and international public health partners. Case numbers are subject to change as the situation evolves.

The risk of spread to the United States is considered low at this time. However, it is possible for travelers from affected areas in DRC or Uganda to enter the United States. Therefore, as an additional precaution, CDC is working to raise awareness of this outbreak among travelers, public health departments, public health and clinical laboratories, and healthcare workers in the United States.

Ebola disease is caused by a group of viruses known as orthoebolaviruses (formerly ebolavirus). Ebola disease most commonly affects humans and nonhuman primates, such as monkeys, chimpanzees, and gorillas. Four orthoebolaviruses cause illness in people, presenting as clinically similar disease:
  • Ebola virus (species Orthoebolavirus zairense) causes Ebola virus disease.
  • Sudan virus (species Orthoebolavirus sudanense) causes Sudan virus disease.
  • Taï Forest virus (species Orthoebolavirus taiense) causes Taï Forest virus disease.
  • Bundibugyo virus (species Orthoebolavirus bundibugyoense) causes Bundibugyo virus disease.
The incubation period for BVD ranges from 2 to 21 days after exposure. A person infected with an orthoebolavirus is not considered contagious until after symptoms appear. Early "dry" symptoms include fever, aches, pains, and fatigue and later "wet" symptoms include diarrhea, vomiting, and unexplained bleeding. Ebola disease is spread through direct contact (through broken skin or mucous membranes) with the body fluids (e.g., blood, urine, feces, saliva, semen, or other secretions) of a person who is sick with or has died from Ebola disease. Ebola disease can also be transmitted to humans from infected animals, or through contact with objects like needles that are contaminated with the virus. Ebola disease is not spread through airborne transmission.

In the absence of early diagnosis and appropriate supportive care, Ebola disease has a high mortality rate. There is currently no Food and Drug Administration (FDA)-licensed or authorized vaccine to protect against Bundibugyo virus infection. The Ebola vaccine licensed in the United States (ERVEBO®) is indicated for preventing Ebola disease due to a different species of Ebola virus (species Orthoebolavirus zairense) only, and based on studies in animals, this vaccine is not expected to protect against Bundibugyo virus or other orthoebolaviruses. There is currently no FDA-approved or authorized treatment for BVD, but there are therapies that have shown some efficacy in animal models. With intense supportive care and fluid replacement, mortality rates may be lowered.

CDC has developed recommendations for U.S.-based organizations (e.g., nongovernmental, faith-based, academic, or aid organizations) with staff working in affected areas: Recommendations for Organizations Sending U.S.-based Personnel to Areas with VHF Outbreaks.

Recommendations for Clinicians

Recommendations for Public Health Departments

Recommendations for Clinical Laboratory Biosafety

Recommendations for U.S. Travelers

CDC recommends avoiding nonessential travel to Ituri and Nord-Kivu provinces in DRC. If they travel to DRC, travelers should take precautions as described in CDC's level 3 Travel Health Notice, including taking steps to avoid possible exposure to BVD and monitoring themselves for symptoms while in DRC and for 21 days after leaving. Travelers who develop symptoms during this time should self-isolate and contact local health authorities or a clinician.

Travelers to Uganda are recommended to follow recommendations in CDC's level 1 Travel Health Notice including taking steps to avoid possible exposure to BVD and monitoring themselves for symptoms while in Uganda and for 21 days after leaving. Travelers who develop symptoms during this time should self-isolate and contact local health authorities or a clinician.

Recommendations for the Public
  • Protect yourself and prevent the spread of BVD when living in or traveling to a region where Bundibugyo virus is potentially present or that is currently experiencing an outbreak.
  • In affected areas, take the following actions to protect yourself: 
    • Avoid contact with sick people who have symptoms such as fever, muscle pain, and rash.
    • Avoid contact with blood and other body fluids.
    • Avoid materials possibly contaminated with blood or other body fluids of people who are sick.
    • Avoid semen from men who have recovered from BVD until testing shows that the virus is no longer in the semen.
    • Avoid visiting healthcare facilities for nonurgent medical care or for nonmedical reasons.
    • Avoid visiting traditional healers.
    • Do not participate in funeral or burial practices that involve touching the body of someone who died.
    • Keep away from bats, forest antelopes, non-human primates (e.g., monkeys, chimpanzees, gorillas), and avoid contact with blood, fluids, or raw meat from these or unknown animals.
    • Do not enter areas where bats live, such as mines or caves.
  • Monitor your health while you are in, and for 21 days after you return from, an area experiencing a BVD outbreak.
    • If you develop any symptoms of BVD during this time, isolate (separate) yourself immediately from others, do not travel, and contact local health authorities or a healthcare facility for advice.
    • Before you enter a healthcare facility, alert the healthcare providers of your recent presence in a BVD-affected area.

Over the past 3 weeks we've seen 2 viral outbreaks (hantavirus & Ebola) emerge from out of left field - and while I believe both will be contained - it is a reminder of how quickly the viral landscape can change. 

The next pandemic virus is likely already out there, in a bat, a mouse, or a bird; just looking for the right opportunity (or evolutionary change) to enable it to jump species and begin its world tour. 

Meanwhile we continue to dismantle our global surveillance and reporting systems, we resist aggressive testing of livestock, and we've cut funding for both basic research and public health systems.

But at least when next pandemic crisis invariably does appear, our leaders will be able to shake their heads and honestly say; `No one saw it coming.'

Norway Veterinary Institute Reports HPAI H5N5 In Polar Bears on Svalbard Island

 
and spillover to mammals

#19,167

Although H5N1 remains the overwhelmingly dominant HPAI H5 subtype reported around the globe, we continue to follow other H5 subtypes bubbling up around the globe. 

  • Last February, in South Korea: H5N9 Rising, we looked at concerns over the arrival this past winter of a triad of HPAI H5 viruses in Korea; H5N1, H5N6, and H5N9.
While running a distant 2nd place to H5N1, H5N5 has shown surprising tenacity as it expands its geographic range, and reassorts with other LPAI viruses (see March 2026's Viral Creep: H5N5 Update)

In the summer of 2022, the Norwegian Veterinary Institute reported both H5N1 and H5N5 for the first time in wild birds on Svalbard, which lies above the Arctic circle (see More HPAI (H5N5 & H5N1) Detected In Arctic (Svalbard).


Since then we've been tracking a small - but growing - number of spillovers of H5N5 to mammals in both Europe and Canada, including seals in the UK, domestic cats in Iceland, and raccoons (and other small mammals) in Canada.

Two summers ago (2024) in Cell Reports: Multiple Transatlantic Incursions of HPAI clade 2.3.4.4b A(H5N5) Virus into North America and Spillover to Mammals, researchers reported finding the mammalian adaptive E627K mutation in a number of samples.

While we typically see a drop in HPAI reports over the summer, it is because many of their avian hosts have migrated to their high latitude roosting spots - where they may find new opportunities to reassort and evolve - before returning next fall.  

All of which brings us to a new report from the Norway Veterinary Institute, which describes the recent detection of HPAI H5N5 virus in both a dead walrus and a polar bear on Svalbard Island. 

Although no other animals were confirmed infected during this investigation, there are eye witness accounts of two other polar bears exhibiting potential neurological symptoms. 

I've reproduced the NVI statement below. Follow the link for additional photos and references.       

 (Translation)
First detection of avian influenza in polar bears in Svalbard
Published 19.05.2026

The Norwegian Veterinary Institute has detected avian influenza in a one-year-old male polar bear and an adult walrus in Raudfjorden north of Spitsbergen. This is the first time the virus has been detected in polar bears in Norway and Europe.

Avian influenza virus was detected in a brain sample from the polar bear.  

The detected avian influenza virus (HPAI) is of the subtype H5N5, a type of the virus that has also been previously detected in Svalbard: In wild birds in 2022, in a walrus in 2023 and in mountain foxes in 2025. This latest detection is the first in polar bears in Norway and Europe. *

Avian influenza viruses have also previously been detected in carnivorous mammals such as red foxes, otters and lynxes on mainland Norway after infection from wild birds.

Sampled in the field

In mid-May, the Norwegian Veterinary Institute was notified by the Norwegian Polar Institute of the discovery of a dead polar bear and a dead walrus in Raudfjorden on Svalbard. The animals were first observed by tourist guides. Two polar bears were also observed in the area showing lameness in their hind legs. This may be a neurological sign, which has previously been observed in polar bears infected with rabies and predators infected with highly pathogenic avian influenza.

"This gave us suspicion of a serious infectious disease, and two of us from the Veterinary Institute traveled to Svalbard to assist the Governor with sampling the dead animals in the field. With the help of a helicopter, the carcasses were quickly found and we were able to take samples. We observed no more sick polar bears from the air," says veterinarian and wildlife health specialist Knut Madslien.Walrus carcass on the shore in Svalbard. Despite the walrus being very rotten, it was still possible to detect the bird flu virus in the brain.  

The samples were then sent to the Veterinary Institute and tested for avian influenza virus and rabies virus. Highly pathogenic avian influenza (HPAI) virus was detected in the samples from both the polar bear and the walrus. Rabies virus was not detected.

Bird flu virus is circulating in the highlands

"The findings are part of a trend where highly pathogenic avian influenza virus is increasingly being detected in mammals in Europe. At the same time, the virus has spread to new areas in recent years, including the Arctic, where it may have consequences for vulnerable populations and ecosystems," explains Ragnhild Tønnessen, avian influenza coordinator at the Norwegian Veterinary Institute.

“It is important to monitor the situation to understand developments and manage risk,” says Madslien.

Increased infection pressure in mammals

Most avian influenza viruses are best adapted to be transmitted between birds. However, mammals can sometimes be infected with avian influenza through direct contact with birds or other mammals infected with the virus, either sick or dead.

The Veterinary Institute will conduct further investigations of the detected virus to check whether it shows signs of being specifically adapted to mammals.
First detection in polar bears in Europe

In other predators, such as red foxes and lynxes, avian influenza can cause clinical signs of brain disease similar to those seen in rabies. Neurological signs such as circling gait, tilted head position, paralysis, and decreased shyness towards humans are common.

Avian influenza virus in polar bears has been scientifically published once before, in a young male polar bear found dead in Alaska in August 2023. It is not known how the virus affects individual individuals and the polar bear population.

Report if you observe dead or sick animals and birds

Both highly pathogenic avian influenza and rabies are serious diseases that can be transmitted to humans. Therefore, it is important to avoid contact with sick animals.

If avian influenza is suspected in birds and other animals on the mainland, the Norwegian Food Safety Authority must be notified . If sick or dead animals are observed in Svalbard, it is important that the findings are reported to the Governor .

The Norwegian Veterinary Institute is the national reference laboratory for avian influenza and has molecular methods for the detection and characterization of avian influenza viruses.

Tuesday, May 19, 2026

CDC HAN #00529: 2026 Hantavirus Outbreak: Testing for Potential Infection


Credit CDC


#19,166

Lest we forget with all that is going on with the Ebola outbreak in central Africa; the world is still on watch for additional cases of the Andes virus stemming from the outbreak aboard the m/v Hondius. 

Yesterday the CDC released a HAN (Health Alert Network) update on this outbreak (see below). While of primary interest to clinicians, I've reproduced it below.

This update also reminds clinicians to consider other hantaviruses (New World & Old World) when confronted with patients with suggestive symptoms and exposure to sylvatic rodents or rodent excreta. 

First the HAN update, then I'll return with a bit more.

2026 Hantavirus Outbreak: Testing for Potential Infection
May 18, 2026

At a glance
Distributed via the CDC Health Alert Network
May 18, 2026
CDCHAN-00529



Summary

The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Update to inform clinicians and health departments about testing available for patients with suspected hantavirus infection to include Andes virus. CDC first issued a Health Advisory (CDCHAN-00528) about this outbreak on May 8, 2026.
Hantaviruses are a group of viruses that typically spread to people who come in contact with sylvatic rodents. These viruses can cause severe illness or death in humans. Andes virus, a type of hantavirus endemic in South America, is the only type of hantavirus that is known to spread from person to person. Several other New World hantaviruses are endemic to the United States and are not transmissible from person to person. New World hantaviruses can cause hantavirus pulmonary syndrome (HPS), a potentially serious disease that can cause damage to the lungs.

On May 2, 2026, an outbreak of Andes virus on a cruise ship was reported to the World Health Organization (WHO). This outbreak has raised the possibility of cases being imported to the United States. As of May 18, no confirmed cases of Andes virus associated with the outbreak on the cruise ship have been reported in the United States. Therefore, the overall risk to the American public is still considered extremely low at this time. CDC and health departments in several states are monitoring the health of U.S. passengers from the ship and U.S. air travel contacts of symptomatic ship passengers who were subsequently confirmed to have Andes virus infection. This Health Update informs clinicians about testing and consultation that are available for Andes virus and other hantaviruses endemic to the United States, South America, and other nations.

Background

On May 2, 2026, WHO was notified of a cluster of severe acute respiratory illness (SARI) among passengers and crew aboard the M/V Hondius cruise ship in the Atlantic Ocean. On May 6, 2026, WHO confirmed that the cluster was caused by Andes virus, a hantavirus endemic in areas of South America that can cause hantavirus pulmonary syndrome (HPS). Andes virus is the only hantavirus known to spread from person to person. This type of transmission is rare for hantaviruses and is generally associated with prolonged close contact. As of May 15, WHO has reported 10 cases (8 of them laboratory-confirmed), including 3 deaths.

Hantaviruses cause two syndromes. Hantaviruses found in the Western Hemisphere are often referred to as New World hantaviruses and can cause HPS. Several New World hantaviruses that do not spread person to person are endemic in the United States. These include Sin Nombre virus, the virus mostly commonly associated with U.S. HPS cases. In addition to HPS, hantaviruses can cause other clinically significant illness. Hemorrhagic fever with renal syndrome (HFRS) is a group of clinically similar illnesses that affect the kidneys. HFRS is caused by another group of hantaviruses, often referred to as Old World hantaviruses, that are found mostly in Europe and Asia. However, Seoul virus, a type of hantavirus that causes HFRS, is found worldwide, including in the United States. Non-HPS hantavirus infection can also occur, in which patients experience non-specific viral symptoms without cardio-pulmonary symptoms.

Hantavirus infections can occur year-round but are reported more frequently during the spring and summer months when rodent populations increase and people may have greater exposure to rodent-infested environments such as cabins, sheds, campsites, and homes. The most common hantavirus that causes HPS in the United States is spread by the deer mouse. Andes virus is spread primarily by the long-tailed pygmy rice rat (Oligoryzomys longicaudatus).

Recommendations for Clinicians

Consider Andes virus infection in patients who
(1) have symptoms compatible with hantavirus infection,
AND
(2) were aboard the M/V Hondius cruise ship OR had direct contact with someone associated with the M/V Hondius Andes virus outbreak.
Contact your state, tribal, local, or territorial health department immediately to report a suspected Andes virus case and for assistance with diagnostic testing for Andes virus. 
Know that assays designed to specifically detect Andes virus may not detect other New World hantaviruses endemic in the United States.
Consider infection with other New World hantaviruses in patients who
(1) have symptoms compatible with hantavirus pulmonary syndrome (HPS) or non-HPS hantavirus infection,
AND
(2) have a history of known or suspected exposure to sylvatic rodents or rodent excreta (e.g., urine, droppings, or nesting materials).
Consider infection with Old World hantaviruses in patients who
(1) have symptoms consistent with hemorrhagic fever with renal syndrome (HFRS),
AND
(2) have a history of known or suspected exposure to sylvatic rodents or rodent excreta (e.g., urine, droppings, or nesting materials).

Test for non-Andes hantavirus in patients who have symptoms compatible with hantavirus infection and have a history of rodent exposure, but who are not associated with the M/V Hondius Andes virus outbreak.

Consult with CDC's Viral Special Pathogens Branch (VSPB) to discuss hantavirus diagnostic testing by calling the CDC Emergency Operations Center at 770-488-7100 and requesting VSPB's on-call epidemiologist. VSPB cannot accept specimens without prior consultation.

        (Continue . . . )

As we discussed last year, in Two Recent Studies On the Host Range of Hantaviruses In the United States, hantavirus infections are likely under reported in this country.

Credit CDC

Most Hantavirus cases are sporadic, but occasionally we see clusters. Exposure is often linked to cleaning out sheds and garages in the late spring and summer when mouse activity is high. The CDC has a 20-page PDF guide on reducing exposure risks.


For some past blogs on Hantaviruses, you may wish to revisit:

CDC Statement on the Use of Public Health Travel Restrictions to Prevent the Introduction of Ebola Disease into the United States

Scheduled airline traffic around the world – Credit Wikipedia

#19,165

While reassuring the public that the current risk to Americans from the Ebola outbreak in the DRC is `low', yesterday the CDC announced enhanced screening of travelers and imposed `Entry restrictions on non-US passport holders'  if they have visited Uganda, DRC, or South Sudan in the past 3 weeks.

This invocation of Title 42, and a de facto `travel ban' for non-US passport holders is noticeably more restrictive than what we saw during the 2014-2015 Ebola outbreak in West Africa (see CDC Statement On Airport Screening Of Arrivals From West Africa).

First the CDC statement, after which I'll return more on the checkered history of interdicting diseases at ports of entry. 

CDC Statement on the Use of Public Health Travel Restrictions to Prevent the Introduction of Ebola Disease into the United States

For Everyone
May 18, 2026

What to know

On May 18, 2026, CDC, DHS, and other appropriate federal agencies implemented enhanced travel screening, entry restrictions, and public health measures to prevent Ebola disease from entering the United States amid ongoing outbreaks in East and Central Africa.

Statement on Title 42 Order

Title 42 Order

Title 42 Order Suspending the Right to Introduce Certain Persons from Countries Where a Quarantinable Communicable Disease Exists

The Centers for Disease Control and Prevention (CDC), and the Department of Homeland Security (DHS), and other appropriate federal agencies, are taking proactive measures to protect the health and safety of the American public in response to ongoing Ebola Virus Disease (EVD) outbreaks.

Under authority granted by Sections 362 and 365 of the Public Health Service (PHS) Act, 42 U.S.C. §§ 265, 268, and their implementing regulations, CDC is implementing targeted public health measures intended to reduce the risk of Ebola disease caused by the Bundibugyo virus (EVD) by preventing its introduction into the United States. These actions are based on current epidemiological evidence, ongoing risk assessments, and the highly serious nature of EVD. This order will be in effect for 30 days, effective immediately.

Effective immediately, CDC will:
  • Enhance public health screening and traveler monitoring for individuals arriving from areas affected by Ebola outbreaks in the region.
  • Entry restrictions on non-US passport holders if they have been in Uganda, DRC, or South Sudan in the previous 21 days.
  • Coordinate with airlines, international partners, and port-of-entry officials to identify and manage travelers who may have been exposed to Ebola virus.
  • Enhance port health protection response activities, contact tracing, laboratory testing capacity, and hospital readiness nationwide.
  • Continue deployment of CDC personnel to support outbreak containment efforts in affected regions.
At this time, CDC assesses the immediate risk to the general U.S. public as low, but we will continue to evaluate the evolving situation and may adjust public health measures as additional information becomes available.

If you have traveled through the affected countries you are encouraged to monitor CDC travel health notices and seek medical attention immediately if you develop symptoms consistent with Ebola, including fever, weakness, vomiting, diarrhea, or unexplained bleeding, within 21 days of travel to affected areas.

As we discussed in 2014's The New Normal: The Age Of Emerging Disease Threats, the reality of life in this third decade of the 21st century is that disease threats that once were local, can now spread globally in a matter of hours or days.

Between asymptomatic (or presymptomatic) carriage, and long incubation periods, vast oceans and prolonged travel times no longer protect us against infected travelers crossing borders.

Globally, airlines handle over 5 billion passengers and over 40 million flights per year; that's roughly 12 million passengers and 100,000 flights each day. In the U.S. there are roughly 160 airports which handle international flights. 

With incubation periods that can range from a couple of days to several weeks, anyone who is recently exposed could easily change planes and continents several times before ever they ever show signs of illness.

Previous failed attempts to prevent the spread of H1N1 pandemic flu and COVID illustrate just how difficult interdiction really is. 

None of this is to say there is no value in trying to detect, and quarantine, potentially infected travelers coming from an outbreak region; only that we need to temper our expectations.

Surveillance can often identify acutely ill individuals when they are likely to be the most contagious so they can be promptly isolated, and it can provide important surveillance information. And it might even help slow the rate of entry of an emerging disease into a region, allowing additional time to mount public health interventions.

But as far as preventing an infectious disease like Ebola, MERS-CoV, or novel Flu from entering this - or any other country - airport screening is unlikely to provide much in the way of long-term protection. 

The best place to try to stop the next pandemic is not at the inbound passenger gate, but in the places around the world where they are most likely to emerge.

But in our increasingly chaotic and insular world, that goal seems less obtainable with every passing day.